These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17548659)

  • 21. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1.
    Mühlbauer M; Cheely AW; Yenugu S; Jobin C
    Immunology; 2008 Jun; 124(2):256-64. PubMed ID: 18284470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition.
    Barnich N; Aguirre JE; Reinecker HC; Xavier R; Podolsky DK
    J Cell Biol; 2005 Jul; 170(1):21-6. PubMed ID: 15998797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal bacteria from Crohn's disease patients more potently activated NOD-like receptors and Toll-like receptors in macrophages, in an IL-4-repressible fashion.
    Gu J; Liu G; Xing J; Song H; Wang Z
    Microb Pathog; 2018 Aug; 121():40-44. PubMed ID: 29752990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations.
    Lakatos PL; Lakatos L; Szalay F; Willheim-Polli C; Osterreicher C; Tulassay Z; Molnar T; Reinisch W; Papp J; Mozsik G; Ferenci P;
    World J Gastroenterol; 2005 Mar; 11(10):1489-95. PubMed ID: 15770725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.
    Billmann-Born S; Till A; Arlt A; Lipinski S; Sina C; Latiano A; Annese V; Häsler R; Kerick M; Manke T; Seegert D; Hanidu A; Schäfer H; van Heel D; Li J; Schreiber S; Rosenstiel P
    J Immunol; 2011 Apr; 186(7):4027-38. PubMed ID: 21335489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of nod2 in the response of macrophages to toll-like receptor agonists.
    Pauleau AL; Murray PJ
    Mol Cell Biol; 2003 Nov; 23(21):7531-9. PubMed ID: 14560001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?
    Vavricka SR; Rogler G
    Swiss Med Wkly; 2009 Sep; 139(37-38):527-34. PubMed ID: 19838869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands.
    End C; Bikker F; Renner M; Bergmann G; Lyer S; Blaich S; Hudler M; Helmke B; Gassler N; Autschbach F; Ligtenberg AJ; Benner A; Holmskov U; Schirmacher P; Nieuw Amerongen AV; Rosenstiel P; Sina C; Franke A; Hafner M; Kioschis P; Schreiber S; Poustka A; Mollenhauer J
    Eur J Immunol; 2009 Mar; 39(3):833-42. PubMed ID: 19189310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-122 targets NOD2 to decrease intestinal epithelial cell injury in Crohn's disease.
    Chen Y; Wang C; Liu Y; Tang L; Zheng M; Xu C; Song J; Meng X
    Biochem Biophys Res Commun; 2013 Aug; 438(1):133-9. PubMed ID: 23872065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.
    Netea MG; Kullberg BJ; de Jong DJ; Franke B; Sprong T; Naber TH; Drenth JP; Van der Meer JW
    Eur J Immunol; 2004 Jul; 34(7):2052-9. PubMed ID: 15214053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms.
    Linderson Y; Bresso F; Buentke E; Pettersson S; D'Amato M
    Int J Colorectal Dis; 2005 Jul; 20(4):305-11. PubMed ID: 15800781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD2 Modulates Serotonin Transporter and Interacts with TLR2 and TLR4 in Intestinal Epithelial Cells.
    Layunta E; Latorre E; Forcén R; Grasa L; Castro M; Arias MA; Alcalde AI; Mesonero JE
    Cell Physiol Biochem; 2018; 47(3):1217-1229. PubMed ID: 29913461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
    Brand S; Staudinger T; Schnitzler F; Pfennig S; Hofbauer K; Dambacher J; Seiderer J; Tillack C; Konrad A; Crispin A; Göke B; Lohse P; Ochsenkühn T
    Inflamm Bowel Dis; 2005 Jul; 11(7):645-52. PubMed ID: 15973118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asparagine attenuates hepatic injury caused by lipopolysaccharide in weaned piglets associated with modulation of Toll-like receptor 4 and nucleotide-binding oligomerisation domain protein signalling and their negative regulators.
    Wu H; Liu Y; Pi D; Leng W; Zhu H; Hou Y; Li S; Shi H; Wang X
    Br J Nutr; 2015 Jul; 114(2):189-201. PubMed ID: 26079268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion.
    Till A; Rosenstiel P; Bräutigam K; Sina C; Jacobs G; Oberg HH; Seegert D; Chakraborty T; Schreiber S
    J Cell Sci; 2008 Feb; 121(Pt 4):487-95. PubMed ID: 18256385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease.
    Wang TT; Dabbas B; Laperriere D; Bitton AJ; Soualhine H; Tavera-Mendoza LE; Dionne S; Servant MJ; Bitton A; Seidman EG; Mader S; Behr MA; White JH
    J Biol Chem; 2010 Jan; 285(4):2227-31. PubMed ID: 19948723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF-κB1 inhibits NOD2-induced cytokine secretion through ATF3-dependent mechanisms.
    Zheng S; Abraham C
    Mol Cell Biol; 2013 Dec; 33(24):4857-71. PubMed ID: 24100018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.